Advanced Enzyme Technologies Ltd
BSE: 540025
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 116.41+21.8% | 95.58-17.4% | 115.75-7.4% | 125.02+43.4% | 87.21-13.5% | 100.87+30.4% | 77.38 |
| Other Income | 5.16+299.0% | 1.29-58.0% | 3.08-94.3% | 53.85+1088.8% | 4.53+217.0% | 1.43-13.7% | 1.66 |
| Total Income | 121.57+25.5% | 96.88-18.5% | 118.83-33.6% | 178.88+95.0% | 91.74-10.3% | 102.30+29.4% | 79.03 |
| EXPENSES | |||||||
| Expenditure | 92.73+23.3% | 75.20-15.7% | 89.21-8.5% | 97.48+27.9% | 76.23-6.8% | 81.76+22.6% | 66.71 |
| Tax | 6.55+43.3% | 4.57-37.7% | 7.34-1.1% | 7.42+66.4% | 4.46-16.9% | 5.36+67.7% | 3.19 |
| PROFIT | |||||||
| PBT | 28.84+61.9% | 17.82-39.8% | 29.62-63.6% | 81.40+424.8% | 15.51-24.5% | 20.54+66.7% | 12.32 |
| Net Profit | 22.30+68.3% | 13.25-40.5% | 22.28-69.9% | 73.98+569.3% | 11.05-27.2% | 15.18+66.4% | 9.13 |
| KEY METRICS | |||||||
| OPM % | 23.07%+2.56pp | 20.51%-5.06pp | 25.57%+1.15pp | 24.42%+8.17pp | 16.25%+0.23pp | 16.02%+5.93pp | 10.09% |
| NPM % | 18.34%+4.67pp | 13.67%-5.08pp | 18.75%-22.61pp | 41.36%+29.31pp | 12.05%-2.79pp | 14.84%+3.29pp | 11.55% |
| EPS | 1.99+68.6% | 1.18-40.7% | 1.99-69.9% | 6.61+567.7% | 0.99-27.2% | 1.36+65.9% | 0.82 |
Corporate Events
Board MeetingADVENZYMES
202631Jan
Board Meeting
consider and approve Un-audited Financial Results (Standalon…
BSE Filing ↗ Board MeetingADVENZYMES
20252Aug
Board Meeting
Consider and approve Un-audited Financial Results (Standalon…
BSE Filing ↗ Board MeetingADVENZYMES
202411May
Board Meeting
Consider and approve annual Financial Statements, recommend …
BSE Filing ↗ Board MeetingADVENZYMES
202410Feb
Board Meeting
Consider and approve Un-audited Financial Results (Standalon…
BSE Filing ↗ Board MeetingADVENZYMES
20237Nov
Board Meeting
Consider and approve Un-audited Financial Results (Standalon…
BSE Filing ↗ Board MeetingADVENZYMES
202312Aug
Board Meeting
Consider and approve Un-audited Financial Results (Standalon…
BSE Filing ↗